The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell cycle progression score differentiates indolent from aggressive prostate cancer in men diagnosed by TURP.
 
Jack M. Cuzick
Honoraria - Merck; Mycology; Qiagen; Roche
Consulting or Advisory Role - Atossa Genetics; Cancer Prevention Pharmaceuticals; Merck; Mycology; Qiagen; Roche
Speakers' Bureau - Becton Dickinson; Gen-Probe; Hologic
Research Funding - AstraZeneca (Inst); Aventis Pharma (Inst); Becton Dickinson (Inst); GeneFirst (Inst); Genera Biosystems (Inst); Myriad Genetics (Inst); Qiagen (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Myriad Geneticsto institution of which I receive a share for development of Cell cycle progression score (Prolaris)
Travel, Accommodations, Expenses - GE Healthcare
 
Steven Stone
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Saradha Rajamani
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Henrik Møller
No Relationships to Disclose
 
Daniel M. Berney
Research Funding - Myriad Genetics
 
Todd Cohen
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Consulting or Advisory Role - Johnson & Johnson; Myriad Genetics
Speakers' Bureau - Johnson & Johnson
 
Peter T. Scardino
Stock and Other Ownership Interests - OPKO Health
Consulting or Advisory Role - OPKO Health
Travel, Accommodations, Expenses - Medivation